Stay updated on Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.

Latest updates to the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now indicates that the study is no longer looking for participants, reflecting a closed recruitment status. The version label has been updated to Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedA new revision label v3.5.5 was added to the history, and the previous v3.5.4 label was removed. This reflects a fresh update to the history page without altering study data.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the study's Record History, and the previous Revision: v3.5.3 entry was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page’s displayed revision/version number was updated from “v3.5.2” to “v3.5.3,” indicating a maintenance or software update without altering the recorded trial information.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check78 days agoChange DetectedThe history shows the study is completed with updates to Study Status, Study Design, and Contacts/Locations. Earlier status and sponsor-related details were removed or revised to reflect the current record.SummaryDifference0.8%

Stay in the know with updates to Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.